Why 'Founder-Friendly Terms' Usually Means 'Slow Death

The Narrative Trap: Why “Founder-Friendly” Sounds Good But Usually Isn’t

Quick answer: Founder-friendly terms sound good but hurt you later. Common traps: high participation rights (investors get paid 2-3x while you get nothing), valuation caps on SAFEs ($10M cap sounds protective, then Series A happens at $20M and you’re underwater), and anti-dilution clauses (your ownership dilutes faster than expected). Read terms with a lawyer. “Founder-friendly” is marketing.

I’ve read hundreds of term sheets. I’ve signed four of them as a founder. I’ve invested capital in 200+ startups as an angel, meaning I’ve reviewed the investor side of the table for many more.

Here’s what I’ve learned: The phrase “founder-friendly terms” is usually a marketing sentence, not a legal or financial one.

When an investor says their terms are “founder-friendly,” what they often mean is one of three things:

1. “Our lawyers won’t torture you” (true but irrelevant). Some funds use aggressive legal language. Others don’t. But kind lawyering is not the same as good terms. You can have soft-spoken lawyers protecting truly oppressive financials.

2. “We don’t do certain bad practices” (sometimes true, usually incomplete). Some funds say “we don’t do 1x preference” or “we don’t require liquidation preferences.” That sounds generous. But if they’re also taking a 25% dilution stake, controlling the board, and reserving the right to block exit votes, you’ve traded one problem for a worse one.

3. “We’ve met other founders and we know what words feel good” (marketing speak). The smartest anti-founder investors have learned that founders respond to certain signals. So they optimize for those signals while keeping the structural power on their side.

The real framework for evaluating terms isn’t emotional. It’s structural. Does this agreement preserve your optionality, your control, and your upside? Or does it slowly compress all three?

This article teaches you what actually protects founders, what terms you should care about, and how to spot the difference between investor marketing and actual founder protection.

---

What Investors Mean by “Founder-Friendly” (In Reality)

Let me translate the investor language into what’s actually happening.

For related context, see clarity about term conditions, negotiating term sheet conditions, and Series A term pitfalls.

Translation 1: “We Have a Clean Legal Process”

What they’re saying: “We won’t make your lawyers spend 10 weeks negotiating every comma.”

What it means: The legal friction is lower. That’s real, and it saves you money.

What it doesn’t mean: Your economic terms are good. A fast process can produce a bad outcome. A slow process can produce a good outcome. Speed is not protection.

Red flag if: They make this the centerpiece of their “founder-friendly” pitch. If they’re only selling you on clean process, what else are they hiding?

Translation 2: “We Don’t Do 1x Liquidation Preference”

What they’re saying: “We’re not taking all the money if you exit below our purchase price.”

What it means: If your company exits for €10M and they invested €2M at 1x pref, they don’t get all €10M off the top. Good.

What it doesn’t mean: You’re protected. A 2x or 3x preference is still oppressive. A non-participating preference is less bad than participating. But the real problem isn’t the preference ratio; it’s often the board control that came with their capital.

Red flag if: They claim 1x pref is “founder-friendly” and then you realize they’re also taking 50% board control. The preference matters less than the governance.

Translation 3: “We Don’t Have a Board Seat”

What they’re saying: “You get to run the company; we don’t veto decisions.”

What it means: They don’t attend board meetings; you keep operational control.

What it doesn’t mean: You have full control. If they also have information rights, pro-rata rights, and investor class voting rights, they can still block a sale, force a down round, or make your life difficult through other mechanisms.

Red flag if: They don’t take a board seat but they’re taking 30%+ of your company. That’s a lot of economic upside to have no governance voice. Usually it means they’re taking protective mechanisms elsewhere in the cap table.

---

The Real Costs of Bad Terms: Dilution Cascade, Control Loss, Exit Barriers

Let me show you what actually happens when you misunderstand terms, using three real patterns I’ve seen.

Pattern 1: The Dilution Cascade

You raise a seed round: €500K at 20% dilution. You think: “I still own 80%. That’s fine.”

Then Series A: €2M at 25% dilution. You think: “Okay, I’m down to 60%. But the valuation is 5x. I’m rich on paper.”

Then Series B: €5M at 30% dilution. By this point, you own 42%.

Then a down round Series C (€2M at 50% dilution for anti-dilution protection for Series A and B investors). You own 20%.

What happened? Your equity didn’t “get diluted.” Your equity got compressed by design. Each round included anti-dilution clauses that protected earlier investors. Each round included option pool reserves that compressed founder equity further.

By Series C, you’re not a co-founder anymore. You’re an employee. And you own 20% of a company now doing €20M revenue (which should be worth founder control, not employee status).

The founder-friendly thing? Watch anti-dilution scope closely. Non-participating preferred is less bad than participating. Narrow-based is better than full-ratchet. But the real issue is whether you understand the cascade before you sign the seed agreement.

Most founders don’t. They sign a seed term sheet without modeling what happens if Series A comes in at a lower valuation. Then Series A happens at a lower valuation, and suddenly their equity structure is completely different from what they expected.

Pattern 2: The Control Loss You Didn’t Negotiate

You raise €1M from an investor who takes 20% of your company. Your term sheet says: “Board of three. You appoint one director, your co-founder appoints one, the investor appoints one.” You think: “We have two of three. We control the board.”

But here’s what else is in the term sheet (usually in a section called “Series A Preferred Stock Voting”):

• Any change to the number of board seats requires the investor’s consent
• Any sale, merger, or acquisition requires the investor’s consent (they have a veto)
• Any additional round above your agreed-upon valuation requires the investor’s consent
• Any change to the option pool size requires the investor’s consent
• Any dividend or distribution requires the investor’s consent

What actually happened? You don’t control the board. The investor controls the company. You control the day-to-day, but they control the exits, the capital, and the future. You have “operational control” but zero strategic control.

The founder-friendly thing? Don’t assume a 2-of-3 board means you control anything. Read the voting rights section. See what actually requires investor consent. If an exit requires their consent, you’re not free to sell.

Pattern 3: The Exit Barrier

It’s now Year 5. A strategic acquirer makes an offer: €50M. You want to sell. You’re tired. You’ve raised three rounds. Half your team is burnt out.

Your current cap table has:

• 3 institutional investors (Series A, B, C)
• 12 angels with pro-rata rights (if you sell, they get to buy back up to their pro-rata ownership)
• 4 option holders who’ve exercised but not fully vested
• 2 early employees with acceleration provisions

To close the sale: Every investor has to sign the sale agreement. If one investor feels their terms aren’t being met, they can hold up the deal. Not maliciously—just protecting their interests as the agreement allows them to do.

If you have a liquidation preference waterfall that stacks (Series A gets paid first, then B, then C, then angels), and the sale price is only €50M, the math might show that angels get almost nothing. So they push back. They demand better terms or they threaten to block by not signing.

You now have 15 people who have to agree to your exit, and several of them aren’t aligned with your timeline or outcome.

What made this worse? Every single round you signed agreements that preserved investor optionality at the cost of your flexibility. You traded founder control for investor-favorable mechanisms in the name of “standard terms.”

The founder-friendly thing? Fewer investors is always better than more, all else equal. If you can raise your Series A from one or two investors instead of three, do it. The cap table stays simpler. Exit alignment stays easier.

---

What Actually Protects Founders (Not What The Narrative Says)

Now let’s talk about what’s actually in a good term sheet for a founder.

Actual Protection 1: Founder Board Seat + Voting Control

This matters more than liquidation preference ratio.

What to look for:

• You or your co-founder have a board seat (not just board observation rights, but actual voting rights)
• Board decisions require your affirmative vote for: company sale, merger, additional fundraising above a specific valuation, major product pivots, liquidation, sale of material assets
• You have information and inspection rights (you see financial statements, investor updates, cap table changes monthly)

Why this matters: If you control strategic decisions, you can protect the company even if you don’t own the most equity. If you can see the financials monthly, you catch problems early instead of finding out in a down round. If you have veto rights on a sale, you’re actually free to negotiate.

What founders often accept instead: Board observation rights (you attend but can’t vote). Board seat with limited voting (you can vote on operational stuff but not strategy). No information rights (you don’t see the cap table until you need to refinance).

Translation: You’re not actually in control.

Actual Protection 2: Pro-Rata Rights for You, Not Just Investors

Here’s a subtle one that most term sheets miss.

Investors always get pro-rata rights: if you raise Series B, they get to buy more to maintain their ownership percentage.

Founders usually don’t get the same protection.

What to push for:

• Pro-rata right for all founder equity shares (if you own 30% and there’s a new round, you get to buy more to stay at 30%)
• Carve-out from the 20% dilution guideline (most VCs target 20% dilution per round; your founder shares shouldn’t count against that)

Why this matters: Founder pro-rata keeps you from getting diluted out of meaningful ownership. Without it, Series B dilutes you 20%, Series C dilutes you another 20%, and you’re at 10% within 4 rounds.

What you often get instead: No pro-rata clause for founders. An option pool that grows with each round, which counts against your ownership.

Translation: You’re diluted by design, not accident.

Actual Protection 3: Acceleration on Change of Control

This is a “founder-friendly” provision that most founders misunderstand.

What it means: If the company is sold, all your vesting equity vests immediately. Without acceleration, a sale could mean you lose 50% of your equity because you haven’t vested it yet.

Why it matters: In an acquisition, you need bargaining power. If you can say “I own 30% vested plus another 30% that vests on sale,” you’re in a stronger position than if you say “I own 30% but 50% of it is unvested and I lose it if they don’t hire me.”

What to negotiate:

• Single-trigger acceleration on change of control (you own it the moment the sale happens, regardless of your employment status)
• If single-trigger is a dealbreaker, double-trigger acceleration (you own it if you’re fired or if you leave after the sale)

Actual Protection 4: Anti-Dilution That Doesn’t Crush Future Investors

This sounds founder-friendly but it’s actually complicated.

Anti-dilution protects investors if a future round is at a lower valuation. There are two types:

Full-ratchet: If Series B is at a lower valuation, your Series A price per share drops to match. This is brutal. It means your later investors get crushed, and you can’t raise capital at lower valuations without major dilution.

Broad-based weighted average: If Series B is lower, your Series A price adjusts, but it’s proportional to the round size. Less brutal.

Narrow-based weighted average: Same math, but using fewer shares in the calculation. Even less brutal.

No anti-dilution: Series A price stays the same; if Series B is lower, investors just own more shares.

What to negotiate:

• Push for no anti-dilution (cleanest for the cap table)
• If you must accept it, narrow-based weighted average (less destructive)
• Never accept full-ratchet (it will come back to haunt you when you need to raise down-round capital)

Why this matters: Anti-dilution is sold as investor protection, but it’s actually a tax on founders and future investors. Full-ratchet anti-dilution means your Series B investor faces crushing terms if they raise a Series C, which means they won’t, which means you can’t raise more capital.

---

Key Terms to Care About: Liquidation Preference, Anti-Dilution, Board Control, Exit Rights

Let me break down the specific terms in a term sheet and what each one actually means for you.

Term 1: Liquidation Preference (Valuation Protection)

What it says: “If the company is sold, liquidated, or merges, the holder of preferred stock gets paid before common stock holders.”

Why investors want it: They need to know they’ll recover their capital if the sale is below their purchase price.

The spectrum:

• 1x preference (non-participating): Investor gets either their purchase price or their pro-rata share of the exit, whichever is higher. You get the rest. This is genuinely better.
• 2x or 3x preference: Investor gets 2x or 3x their investment off the top. Only what’s left goes to founders.
• Participating preference: Investor gets their preference plus pro-rata share of remaining proceeds. Crushes founder upside.

What to negotiate:

• 1x non-participating is the floor
• Avoid 2x, 3x, or participating at all costs
• If you must accept higher preference, negotiate a cap (e.g., “1x preference capped at 10% of exit proceeds”)

Why it matters: A €50M exit with 3x preference for a €2M investment means the investor gets €6M off the top before founders see anything. With 1x, the investor gets €2M off the top, and the remaining €48M is split by ownership percentage.

Term 2: Anti-Dilution Protection (Future Round Protection)

What it says: “If future rounds are at lower valuations, your price per share adjusts downward to protect your investment.”

Why investors want it: Downside protection if the company underperforms.

What to negotiate:

• No anti-dilution if possible
• If you must accept it, weighted-average (narrow-based)
• Exclude anti-dilution if you raise at a lower valuation by founder choice (debt, secondary sales, option pool refreshes)

Why it matters: Full-ratchet anti-dilution means a Series B down round at half valuation makes your Series A price per share drop in half, effectively doubling their ownership without more capital. This cascades: now your Series C investor looks at the dilution and demands the same, and your Series B faces crushing dilution. Your ability to raise future capital at realistic valuations becomes impossible.

Term 3: Board Control (Who Actually Decides)

What it says: “Board composition and voting rights.”

Why investors want it: Veto power on major decisions to protect their investment.

What to negotiate:

• Founder or co-founder has a board seat
• You have voting control over: sale, merger, major financing, cap table changes, strategic pivots
• You have monthly financial reporting and cap table visibility
• Board meetings happen at least monthly (no surprise governance shifts)

Why it matters: Without board control, you can be forced to make decisions you don’t agree with. You can be forced into a down round, a failing pivot, or a sale at a bad price. You can be kept in the dark about company health until it’s too late.

Term 4: Exit Rights (Who Gets To Sell When)

What it says: “The conditions under which the company can be sold, who has to approve, and what happens to proceeds.”

Why investors want it: Veto power on bad exits.

What to negotiate:

• You (or your board if you control it) can approve an exit without investor approval if: sale price is above a pre-agreed valuation floor, OR exit is approved by holders of a majority of common stock, OR exit is part of a strategic plan you’ve shared with investors
• Any sale requires all investor classes to approve pro-rata economics (no underwater investments)
• If you’re forced out as CEO in the exit, your equity accelerates

Why it matters: Without exit rights, a misaligned investor can block your sale even if it’s good for the company. If you own 20% and control the cap table, an investor who owns 15% shouldn’t be able to prevent your exit. If you’re fired as part of an exit, you should still own what you earned.

---

The Terms That Seem Founder-Friendly But Aren’t

Let me call out the specific marketing moves that sound good but hide real dangers.

Fake Protection 1: “No Preference Stake”

What it sounds like: Investor says “We’re not taking preferred stock; we’re taking common stock. We’re aligned with you.”

Why it sounds founder-friendly: Preferred stock is associated with investor protection. Common stock sounds fair.

What’s actually happening: The investor is taking common stock at a much lower price than you raised at, giving them massive dilution upside while you have none. Example: You raised at €2/share. They’re buying common at €0.50/share. They own 2x the shares but claim to be “aligned” because it’s common stock.

How to evaluate: Ask for preference rank and liquidation order, not just the stock class. Common stock without investor pro-rata rights is often worse than preferred with clear terms.

Fake Protection 2: “We’re Taking a Lower Valuation”

What it sounds like: Investor says “We’re investing at a below-market valuation to give you room to grow.”

Why it sounds founder-friendly: Lower valuation means less immediate dilution, right?

What’s actually happening: They’re taking massive upside optionality. If the company does well, they’re sitting on a 10x return. If the company struggles, they have enormous pro-rata or anti-dilution protection to maintain their ownership.

How to evaluate: Calculate what percentage of the company they’re taking at that “low” valuation. If it’s still 20%+, it’s not generous. They’re just getting a better entry price.

Fake Protection 3: “We Don’t Take Board Seats”

What it sounds like: Investor says “We’re passive investors; we don’t want to be in the weeds.”

Why it sounds founder-friendly: You keep full control of the company.

What’s actually happening: They’re taking massive equity stake without governance responsibility. They’re protected by information rights, pro-rata rights, liquidation preferences, and voting rights on exits. They have all the power with no accountability.

How to evaluate: Ask: What can you veto? What decisions require your approval? The answer probably includes exit, major financing, and cap table changes. That’s not passive.

Fake Protection 4: “Lower Valuation Cap”

What it sounds like: Investor says “We’re putting a $15M valuation cap on the SAFE. You get an extra 5% discount if we convert to Series A.”

Why it sounds founder-friendly: Lower valuation = better price for you = less future dilution.

What’s actually happening: They’re lowering the valuation floor to boost their ownership at conversion. If Series A is at $50M valuation, a $15M cap means they convert at a 3.3x return on paper.

How to evaluate: Model the math. Cap-and-discount SAFEs aren’t inherently bad, but calculate what percentage they end up with at realistic Series A valuations. If it’s 20%+, the “discount” isn’t generous.

---

The Founder Protections That Actually Matter: Information Rights, Pro-Rata, Founder Board Seat

Let me contrast the fake stuff with the real protections.

Real Protection 1: Information Rights

What it is: Your right to see financial statements, cap table, and investor updates monthly.

Why it matters: You catch problems early (cash runway, customer churn, quality issues). You have the same information as your board when making decisions. You can model future dilution and plan ahead.

What to negotiate:

• Monthly financial reporting (not quarterly—months matter in early stage)
• Monthly cap table updates if there are any changes
• You see all investor updates that the board sees
• Audit rights if acquisition becomes imminent

Red flag if: Investor says “you’ll see the cap table when you need to fundraise.” That’s too late. You need to know proactively.

Real Protection 2: Pro-Rata Rights for Founders

What it is: Your right to purchase shares in future rounds to maintain your ownership percentage.

Why it matters: You don’t get diluted out by founder investors alone. You have a voice in the future cap table through your ability to buy more. You’re incentivized to stay long-term (you can maintain ownership).

What to negotiate:

• Pro-rata rights for all founder shares (100% of your common stock)
• Priority over option pool refresh in pro-rata allocation
• Carve-out from standard 20% dilution guideline

Red flag if: Pro-rata rights only apply to investors, not to founders. That’s asymmetric power.

Real Protection 3: Founder Representation on Board

What it is: You or a co-founder has a voting seat on the board of directors.

Why it matters: You have veto power on strategic decisions. You’re informed monthly about company health. You can push back on investor pressure in real time.

What to negotiate:

• A founder board seat (not observation rights—actual voting seat)
• Voting control over: sale, merger, financing, cap table changes
• Monthly board meetings at minimum
• Access to all board materials before meetings

Red flag if: Investor offers “observer rights” instead of board seat. Observers attend but can’t vote. That’s theater, not power.

---

How to Evaluate Term Sheet Credibility vs. Marketing

Here’s the practical framework I use when I see “founder-friendly” language in a term sheet.

Step 1: Read the Marketing (Emails and Sales Pitch)

Ignore it. Or at least, note what they’re emphasizing.

If an investor leads with “we’re founder-friendly,” they’re probably selling the sizzle, not the steak. Real protections aren’t marketing messages; they’re legal terms.

Step 2: Read the Actual Preferred Stock Terms

This is the dense section that most founders skip. Don’t.

Pull out:

• Liquidation preference (1x? 2x? participating?)
• Anti-dilution clause (full ratchet? broad-based? none?)
• Voting rights on exits (yes or no?)
• Board seat (yes or no?)
• Pro-rata rights (you or just investors?)

Step 3: Run the Math

Model a few scenarios:

Scenario A: Company does well

• €10M Series A at €50M valuation
• Series B at €200M valuation
• 5-year exit at €500M

Calculate: How much do you own at each stage? How much do you own at exit? How much do investors own? What’s the absolute dollar amount you get?

If Series A had 3x preference and participating rights, you might own 25% at exit but the investor gets €100M off the top, leaving you with €100M on 25%.

Scenario B: Company struggles

• €10M Series A at €50M valuation
• Series B fails; you raise a down round at €20M valuation
• Exit 3 years later at €40M

Calculate: Do you still own what you thought? What does anti-dilution do to your cap table? Can you even raise the Series C you need?

If Series A had full-ratchet anti-dilution, their price per share just dropped to match the down round, and they own 2x the shares. Your equity got halved without any new capital.

Step 4: Compare to Market

You have the reference. What are comparable round terms?

• Seed round at 15-20% dilution, typically 1x preference
• Series A at 20-30% dilution, typically 1x or 2x preference
• Series B at 20-30% dilution, typically 1x or 2x preference

If your terms are dramatically different, understand why. Sometimes there’s a good reason (you negotiated well, or the investor is taking more risk). Sometimes you’re getting a bad deal and the investor is using friendly language to hide it.

Step 5: Get a Lawyer to Review

Don’t try to negotiate term sheets alone.

A startup lawyer who’s seen 100+ rounds will immediately spot:

• Unusual anti-dilution language
• Board control traps
• Pro-rata asymmetries
• Liquidation cascades that hurt you

It costs €3-5K to have a lawyer review a term sheet. That’s 0.3-0.5% of a €10M round. Worth it.

---

The Contrarian Take: Sometimes “Tough” Terms Are More Protective Than “Friendly” Terms

Here’s something that most founders miss.

Sometimes, the “toughest” investors have the clearest, most protective terms.

Why? Because they’ve done this a hundred times. They know what actually matters. They’re not trying to market to you. They’re trying to protect their capital efficiently.

Example:

• Investor A: “We’re founder-friendly. We don’t take board seats. Here’s our flexible term sheet.” (Vague, lots of passive-aggressive clauses about investor rights)
• Investor B: “We take a board seat. We have strong anti-dilution and liquidation preference. Here’s our standard terms.” (Clear, predictable, negotiable on specific points)

Which is better for you? Usually Investor B, because you can negotiate with them (the terms are clear) and you know where you stand.

Investor A might seem easier until you get to Series A and realize their “passive investor” status gave them veto rights on your exit that you didn’t know about.

The lesson: Clarity is better than friendliness. Standard terms are better than custom terms. A tough investor who’s transparent is better than a friendly investor who’s vague.

---

Implementation Notes for Term Sheet Review

For the Seed Round:

1. Get the term sheet. Ask for clarity on:

   • Liquidation preference (target: 1x non-participating)
   • Anti-dilution (target: none, or narrow-based weighted average)
   • Board seat (for you)
   • Pro-rata rights (for you)

2. Hire a lawyer. They’ll catch language you’ll miss. Budget €3-5K.

3. Model dilution through Series B. Calculate ownership at each stage. If you’re below 30% after Series B, renegotiate.

4. Get investor updates in writing. Clarify what pro-rata rights you have. Get it in the agreement, not a verbal promise.

For the Series A Round:

1. Audit your cap table. Know exactly how many shares are reserved, option-adjusted, and at what vesting schedule.

2. Negotiate founder pro-rata rights early. Before Series A closes, lock in your right to maintain ownership in Series B.

3. Lock in information rights. Monthly financials, cap table updates, investor updates. It’s non-negotiable.

4. Board control is non-negotiable. You should have a founder seat or veto rights on exit. Non-negotiable.

Ongoing:

1. Update your cap table model monthly. Know your ownership percentage and the path to exit.
2. Review investor agreements annually. Look for language that limits your future options.
3. Plan for down rounds proactively. Model what your cap table looks like in a down round, and understand what anti-dilution will do.

---

FAQs: Term Sheet Questions Answered

Q: Is 1x preference really “founder-friendly”?

Yes, but only in comparison. 1x non-participating is the baseline. Anything above it (2x, 3x, participating) is investor-friendly. But 1x doesn’t mean you’re protected; it just means you’re not getting crushed by the preference.

Q: What if I can’t get a board seat?

Push for explicit voting rights on exit and major financing. If you can veto a sale, you have de facto control even without a board seat. But board seat is better because you also get information rights and the ability to shape strategy.

Q: Should I ever accept full-ratchet anti-dilution?

Only if you’re raising at a historically low valuation and you’re confident you’ll never do a down round. For most founders: no. Never.

Q: Is a SAFE agreement “founder-friendly”?

SAFEs are faster and cheaper than preferred stock agreements. But they’re not inherently founder-friendly. A SAFE with a low valuation cap can be more dilutive than a preferred stock agreement. Read the terms.

Q: Can I negotiate a term sheet after I’ve signed a LOI?

Yes, but with difficulty. The LOI is a binding agreement to negotiate in good faith, not to accept specific terms. But if you try to dramatically change terms after LOI, the investor might walk. It’s better to negotiate hard before the LOI.

Q: What’s the biggest mistake founders make on term sheets?

Not modeling dilution through Series A and B. They optimize for seed valuation and miss the fact that their ownership gets crushed by Series A anti-dilution. Model the full stack before you sign.

---

{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What's the difference between 1x and 2x liquidation preference?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "With 1x preference, if you exit for €10M and the investor put in €2M at 1x preference, they get €2M off the top and you split the remaining €8M by ownership. With 2x preference, they get €4M off the top. The difference compounds with larger exits. 1x non-participating is the baseline to accept; anything higher is investor-favorable."
      }
    },
    {
      "@type": "Question",
      "name": "Does a board seat actually protect founders?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes, if you have voting control. A board seat without voting rights on major decisions (exit, financing, cap table) is theater. A board seat with voting control on those decisions gives you veto power to protect your interests."
      }
    },
    {
      "@type": "Question",
      "name": "What's the real problem with full-ratchet anti-dilution?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Full-ratchet anti-dilution means that if your Series B round is at a lower valuation, your Series A investor's price per share drops to match. This doubles their ownership without new capital. More importantly, it makes future rounds extremely hard because each investor faces crushing dilution, so nobody wants to lead. You eventually can't raise capital."
      }
    },
    {
      "@type": "Question",
      "name": "Should I get a lawyer to review my term sheet?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes. A startup lawyer costs €3-5K for a review and will catch problems you'll miss. This is 0.3-0.5% of most seed rounds. It's the best investment you'll make."
      }
    },
    {
      "@type": "Question",
      "name": "How do I know if 'founder-friendly' is actually true?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Ignore the marketing language. Read the actual term sheet. Look at: liquidation preference (target 1x non-participating), anti-dilution (target none), board seat (required), pro-rata rights for you (required). If you have those, you're protected. If not, you're not, regardless of what the investor says."
      }
    }
  ]
}

---

Where to Publish

This article will live at: lechkaniuk.com/fundraising/founder-friendly-terms-trap

Internal Linking Suggestions

• Link to: “The One-Pager That Gets You Investor Meetings” (pre-term sheet pitch strategy)
• Link to: “The Hidden Meaning of ‘Send Me Your Deck’” (investor code-switching)
• Link to: “Angels Do Not Invest in Companies, They Invest in Future Decision Quality” (founder judgment under ambiguity)
• Link to: “How to Keep Use When You Are Emotionally Tired” (negotiation psychology during term sheet discussions)

---

Final Note: Your Lawyer Is Your Ally

Term sheets are legally binding documents. Don’t try to negotiate them alone. Get a lawyer. Ask your lawyer to explain every clause in plain English. Ask them to flag the unusual ones.

Most investors expect you to have a lawyer. Many bad terms slip through because founders try to understand 40 pages of legal language alone.

Your cost: €3-5K The value of not accepting bad terms: €1M+ over the life of your company

The math is obvious.

Up Next

• One-Pager That Gets Investor Meetings
• How to Negotiate a Term Sheet
• Negotiate Series A in a Tough Market
• Cap Table Health Check

Frequently Asked Questions

Q: What does “participation rights” actually mean for my bottom line?

Participation means investor gets paid multiple times. On $100M acquisition: investor with 1x participation gets $20M (their original $20M check) but not more. Investor with 2x participation gets $40M (double their check). This comes from your share. Participation above 1x is terrible for founders. Non-participating preferred is ideal, but rare.

Q: Should I worry about anti-dilution clauses?

Yes. Standard anti-dilution is weighted-average (protects investor somewhat). Worst anti-dilution is full ratchet (investor’s share multiplies if Series B is lower valuation). You should never accept full ratchet. Broad-weighted-average is standard. Narrow-weighted-average is founder-friendly. Most angels don’t have explicit anti-dilution — just liquidation preference.

Q: What’s the trap with valuation caps on SAFEs?

High caps ($10M) seem safe but cap your upside. If Series A is $20M, $10M cap means your SAFE converts at massive discount and you’re diluted 40% by one round. Low cap ($3M) is founder-friendly. Ask: “Am I comfortable with 2.5x valuation cap?” If no, get higher cap or skip that investor.

Q: How do I evaluate if a term sheet is actually founder-friendly?

Use math. Run scenarios: $100M acquisition, $500M acquisition, lower Series B. How much do you make? How much does investor make? If you’re getting 30% less in any scenario, something’s wrong. Bring term sheet to lawyer. Lawyers earn their money by catching hidden traps in “founder-friendly” terms.

Q: What should I not negotiate on, even if it sounds bad?

Don’t fight information rights or board observer seats. Do fight: participation rights above 1x, anti-dilution above broad-weighted-average, and liquidation preferences above 1x. The first two are theater. The last two is real money.

Founder-Friendly Terms Trap: Marketing language that makes terms sound good while they actually hurt founders. Common traps: high participation rights, participation preferred (investor gets paid even if you don’t), and aggressive anti-dilution. “Founder-friendly” terms should always be read with a lawyer.